about
Microneedles: A New Frontier in Nanomedicine DeliveryHydrogel-forming microneedles prepared from "super swelling" polymers combined with lyophilised wafers for transdermal drug deliveryThermosensitive hydrogels of poly(methyl vinyl ether-co-maleic anhydride) - Pluronic(®) F127 copolymers for controlled protein release.Release of β-galactosidase from poloxamine/α-cyclodextrin hydrogelsA proposed model membrane and test method for microneedle insertion studies.A novel scalable manufacturing process for the production of hydrogel-forming microneedle arrays.A facile system to evaluate in vitro drug release from dissolving microneedle arrays.Successful application of large microneedle patches by human volunteers.Microneedle characterisation: the need for universal acceptance criteria and GMP specifications when moving towards commercialisation.Transdermal delivery of gentamicin using dissolving microneedle arrays for potential treatment of neonatal sepsis.Repeat application of microneedles does not alter skin appearance or barrier function and causes no measurable disturbance of serum biomarkers of infection, inflammation or immunity in mice in vivo.Zein-Based Nanoparticles Improve the Oral Bioavailability of Resveratrol and Its Anti-inflammatory Effects in a Mouse Model of Endotoxic Shock.Microwave-Assisted Preparation of Hydrogel-Forming Microneedle Arrays for Transdermal Drug Delivery Applications.Non-covalent hydrogels of cyclodextrins and poloxamines for the controlled release of proteins.In vivo studies investigating biodistribution of nanoparticle-encapsulated rhodamine B delivered via dissolving microneedles.Synthesis and characterization of hyaluronic acid hydrogels crosslinked using a solvent-free process for potential biomedical applications.Dissolving microneedles: safety considerations and future perspectives.Hydrogels for Hydrophobic Drug Delivery. Classification, Synthesis and Applications.Novel bilayer dissolving microneedle arrays with concentrated PLGA nano-microparticles for targeted intradermal delivery: Proof of concept.Hydrogels based on poly(methyl vinyl ether-co-maleic acid) and Tween 85 for sustained delivery of hydrophobic drugs.Microarray patches: potentially useful delivery systems for long-acting nanosuspensions.In Vitro release from reverse poloxamine/α-cyclodextrin matrices: modelling and comparison of dissolution profiles.Hydrogel-Forming Microneedle Arrays Made from Light-Responsive Materials for On-Demand Transdermal Drug Delivery.Lignin-based hydrogels with "super-swelling" capacities for dye removal.Transdermal delivery of vitamin K using dissolving microneedles for the prevention of vitamin K deficiency bleeding.Synthesis and Characterization of Lignin Hydrogels for Potential Applications as Drug Eluting Antimicrobial Coatings for Medical Materials.Design and characterisation of a dissolving microneedle patch for intradermal vaccination with heat-inactivated bacteria: A proof of concept studyDesign, formulation and evaluation of novel dissolving microarray patches containing a long-acting rilpivirine nanosuspensionIncreased Oral Bioavailability of Resveratrol by Its Encapsulation in Casein NanoparticlesImplantable Polymeric Drug Delivery Devices: Classification, Manufacture, Materials, and Clinical Applications.Antioxidant PLA Composites Containing Lignin for 3D Printing Applications: A Potential Material for Healthcare Applications.Self-assembled supramolecular gels of reverse poloxamers and cyclodextrinsPhase behavior of reverse poloxamers and poloxamines in waterPegylated poly(anhydride) nanoparticles for oral delivery of docetaxelDevelopment of a Biodegradable Subcutaneous Implant for Prolonged Drug Delivery Using 3D PrintingA Novel Transdermal Protein Delivery Strategy via Electrohydrodynamic Coating of PLGA Microparticles onto Microneedles3D Printing of Pharmaceuticals and Drug Delivery DevicesPotential of Polymeric Films Loaded with Gold Nanorods for Local Hyperthermia ApplicationsNovel nanosuspension-based dissolving microneedle arrays for transdermal delivery of a hydrophobic drugHow innovative drug delivery devices can help realize clinical utility of new effective therapies
P50
Q26767037-1009A7A2-0E6E-48B6-9434-F5782FE758EEQ28544652-1A6CF694-BC7B-41D2-8570-791015BEB90EQ30710572-0964150E-6059-444E-BDFE-6C24195E464AQ33464155-DE56D1F3-3B58-4C2D-A075-97CF8410F4CBQ33953655-88366193-B52D-471B-9013-AE882353CA18Q36181678-B6604738-351A-4A39-85AE-0E0B5FAF8048Q36490572-0DD9F064-904F-4A61-81E5-24840817968AQ37719896-0AADFC06-C92F-450B-8D3C-8A19524A67A5Q38506865-74822A46-2E58-43C4-AE7E-E52F9F4AF620Q40115092-F1751776-3DD4-4376-A1CC-78E789971B78Q40223873-DF34D6B2-DD21-4C06-AEA1-B10FEB551814Q41194371-EB461398-90C1-4441-A541-FCDEE078EAA2Q41252757-D92EC544-4937-401F-ACD0-539F635A1513Q44176831-7690DB52-495A-42B2-A713-2DEE06D90BFDQ47111251-39D3FE4C-2E44-4B66-B87B-C1F8A5ACEB0EQ47238261-D278A6A9-684F-4657-993C-E04603275193Q48146241-ACE64189-B13C-4E83-9FCB-728F811AE93EQ48174596-598C1C9E-8008-4582-B46A-432B4A7606D9Q48629660-75DDDBFD-D562-488B-AEB8-3DBC75ECAAB9Q49901061-761F0B69-35E5-41B6-BBC8-E396BA2C86B6Q50091759-719B123E-54F0-4097-8DA5-3799A2A3F6FCQ51132711-3EB12827-82DD-4A8A-BADC-C7F6E1E01442Q51551559-0192B3E4-B3B5-4F38-B518-1DBBEF48B1F5Q52321310-5A7C5EF7-3D07-4FAD-8AB0-C5EE7437EFBEQ55079183-7A99F088-7F96-4F18-9D02-DC2B0BE9336EQ55661041-4B2F3D4B-42BF-430A-B5F1-87BC3E239177Q56981035-AC1CAFEE-894E-4CE5-98C8-019526B65669Q58616897-1FAD75BD-6E21-4BFB-9FE2-8A8B00A8D57DQ58723030-4EEDF5D0-7D15-49A5-92B5-A09CE8ADF62BQ64915620-EA7D37F5-80C9-4495-BA16-B3651EF483DDQ64949497-E4AA3074-3DCB-44A1-82B1-DBE30AB35F3CQ84600158-0822BBCC-D45F-43FE-AA4F-D2B4F8FECD86Q85750699-D192D33D-76B2-44E8-BC46-8377654DCFBDQ88216440-6056470F-E4D0-4172-A4CA-F992681522F6Q89510821-24507E8D-D9B9-4693-ADBE-66954F911968Q89745526-2FFE5E7F-A9EF-40F3-9650-C15EDCEBC3B9Q90400533-E2E330E6-CFD3-48EC-BA88-7360A4F81752Q90632394-271207C8-FA4E-44AE-B76D-A06D1D641CE2Q90701306-CEE65513-41F5-469B-99DF-8733EC121EC0Q91148489-D861E317-B961-4142-8002-1B173A3EA930
P50
description
researcher
@en
wetenschapper
@nl
հետազոտող
@hy
name
Eneko Larrañeta
@ast
Eneko Larrañeta
@en
Eneko Larrañeta
@es
Eneko Larrañeta
@nl
type
label
Eneko Larrañeta
@ast
Eneko Larrañeta
@en
Eneko Larrañeta
@es
Eneko Larrañeta
@nl
prefLabel
Eneko Larrañeta
@ast
Eneko Larrañeta
@en
Eneko Larrañeta
@es
Eneko Larrañeta
@nl
P108
P106
P1153
55391053300
P31
P496
0000-0003-3710-0438